NASDAQ:COGT | Operating Income | Cogent Biosciences, Inc.

Complete source-backed operating income history.

Available history
2017-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$102.64M
2026-03-31-$103.61M
2025-12-31-$99.49M
2025-09-30-$83.36M
2025-06-30-$75.58M
2025-03-31-$74.93M
2024-12-31-$73.73M
2024-09-30-$75.41M
2024-06-30-$64.39M
2024-03-31-$62.4M
2023-12-31-$58.23M
2023-09-30-$59.58M
2023-06-30-$47.09M
2023-03-31-$43.24M
2022-12-31-$43.75M
2022-09-30-$36.82M
2022-06-30-$35.86M
2022-03-31-$31.42M
2021-12-31-$25.64M
2021-09-30-$19.82M
2021-06-30-$17.29M
2021-03-31-$12.8M
2020-12-31-$11.46M
2020-09-30-$57.2M
2020-06-30-$7.4M
2020-03-31-$6.14M
2019-12-31$2.24M
2019-09-30-$12.04M
2019-06-30-$10.54M
2019-03-31-$11.84M
2018-12-31-$9M
2018-09-30-$10.58M
2018-06-30-$9.44M
2018-03-31-$6.99M
2017-12-31-$6.88M
2017-09-30-$7.17M
2017-06-30-$6.03M
2017-03-31-$6.07M

Annual Operating Income

DateOperating Income
2025-12-31-$333.36M
2024-12-31-$275.94M
2023-12-31-$208.13M
2022-12-31-$147.84M
2021-12-31-$75.55M
2020-12-31-$82.2M
2019-12-31-$32.18M
2018-12-31-$36.01M
2017-12-31-$26.15M